Announcements Trials
Browse Landscape

Phase

Phase NA 4

Status

Completed 13Unknown 4Active not recruiting 4Withdrawn 1Recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4Gastrointestinal 2Tumor-Agnostic 1Other solid neoplasm 1Other neoplasm 1Other 1Genitourinary 1

Conditions

Breast Neoplasms 3Motor Activity 2Triple Negative Breast Neoplasms 1Fatigue 1

Interventions

Paclitaxel 83Fulvestrant 65Trastuzumab 62Letrozole 61pembrolizumab 53Carboplatin 51Cyclophosphamide 48pertuzumab 46palbociclib 44Anastrozole 41Capecitabine 33Tamoxifen 30Magnetic Resonance Spectroscopy 29exemestane 28Radiotherapy 28Doxorubicin 28ribociclib 26olaparib 26Docetaxel 26Specimen Handling 25abemaciclib 24130-nm albumin-bound paclitaxel 20Taxes 19Gemcitabine 19trastuzumab deruxtecan 18durvalumab 18Surveys and Questionnaires 18Epirubicin 18eribulin 17Alpelisib 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Active not recruiting × Resistance Training × Breast × Clear all
NCT04267796 2026-04-16

Lifestyle Intervention for the Reduction of Breast Cancer Risk in Normal Weight Women

M.D. Anderson Cancer Center

Phase NA Active not recruiting
40 enrolled 9 charts
Breast

Breast Neoplasms

NCT07484776 2026-03-20

Metabolic Flexibility in Patients With Early Triple-negative Breast Cancer

Universidad Europea de Madrid

Phase NA Active not recruiting
40 enrolled
Breast

Triple Negative Breast Neoplasms

NCT02999074 2024-12-11

BENEFIT

German Cancer Research Center

Phase NA Active not recruiting
183 enrolled
Breast

Breast Neoplasms, Fatigue, Motor Activity

NCT06618690 2024-10-01

IO/2024

Universidad de Burgos

Phase NA Active not recruiting
325 enrolled
Breast

Breast Neoplasms, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡